These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8176255)

  • 1. Circadian activity of topical 0.05% betamethasone dipropionate in human skin in vivo.
    Pershing LK; Corlett JL; Lambert LD; Poncelet CE
    J Invest Dermatol; 1994 May; 102(5):734-9. PubMed ID: 8176255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical 0.050% betamethasone dipropionate. Pharmacokinetic and pharmacodynamic dose-response studies in humans.
    Pershing LK; Lambert L; Wright ED; Shah VP; Williams RL
    Arch Dermatol; 1994 Jun; 130(6):740-7. PubMed ID: 8002644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching bioassay.
    Pershing LK; Silver BS; Krueger GG; Shah VP; Skelley JP
    Pharm Res; 1992 Jan; 9(1):45-51. PubMed ID: 1589409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New approaches to assess topical corticosteroid bioequivalence: pharmacokinetic evaluation.
    Pershing LK
    Int J Dermatol; 1992 Oct; 31 Suppl 1():14-20. PubMed ID: 1428461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blanching activities of betamethasone formulations. The effect of dosage form on topical drug availability.
    Smith EW; Meyer E; Haigh JM
    Arzneimittelforschung; 1990 May; 40(5):618-21. PubMed ID: 2383308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparative Study to Evaluate Epidermal Barrier Integrity of Psoriasis Patients Treated With Calcipotriene/Betamethasone Topical Suspension Versus Betamethasone Dipropionate 0.05% Lotion.
    Hashim PW; Nia JK; Terrano D; Goldenberg G; Kircik LH
    J Drugs Dermatol; 2017 Aug; 16(8):747-752. PubMed ID: 28809989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo characterization of structural changes after topical application of glucocorticoids in healthy human skin.
    Jung S; Lademann J; Darvin ME; Richter C; Pedersen CB; Richter H; Schanzer S; Kottner J; Blume-Peytavi U; Røpke MA
    J Biomed Opt; 2017 Jul; 22(7):76018. PubMed ID: 28753693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency ranking of two new topical corticosteroid creams containing 0.1% desonide or 0.05% halometasone utilising the human skin blanching assay.
    Meyer E; Smith EW; Haigh JM; Kanfer I
    Arzneimittelforschung; 1988 Dec; 38(12):1840-3. PubMed ID: 3245859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of change in the skin concentration of tazarotene and betamethasone dipropionate based on drug-drug interaction for transdermal drug delivery in miniature pig.
    Yu B; Ma P; Yuan L; Chen D; Yang J
    Xenobiotica; 2015 May; 45(5):380-4. PubMed ID: 25410121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The atrophogenic potential and dermal tolerance of calcipotriol/betamethasone dipropionate ointment compared with betamethasone dipropionate ointment.
    Traulsen J; Hughes-Formella BJ
    Dermatology; 2003; 207(2):166-72. PubMed ID: 12920367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of topical corticosteroid and tacrolimus on ceramides and irritancy to sodium lauryl sulphate in healthy skin.
    Jungersted JM; Høgh JK; Hellegren LI; Jemec GB; Agner T
    Acta Derm Venereol; 2011 May; 91(3):290-4. PubMed ID: 21365172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of dermal bioavailability: predicting the input function for topical glucocorticoids using stratum corneum sampling.
    Pensado A; McGrogan A; White KAJ; Bunge AL; Guy RH; Delgado-Charro MB
    Drug Deliv Transl Res; 2022 Apr; 12(4):851-861. PubMed ID: 34599470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability.
    Wiedersberg S; Naik A; Leopold CS; Guy RH
    Br J Dermatol; 2009 Mar; 160(3):676-86. PubMed ID: 18782322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of glucocorticoids on stratum corneum lipids and function in human skin-A detailed lipidomic analysis.
    Røpke MA; Alonso C; Jung S; Norsgaard H; Richter C; Darvin ME; Litman T; Vogt A; Lademann J; Blume-Peytavi U; Kottner J
    J Dermatol Sci; 2017 Dec; 88(3):330-338. PubMed ID: 28911799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
    Kircik LH
    J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Skin Deposition of Betamethasone Dipropionate from a Novel Formulation and Drug Delivery Technology.
    Draelos ZD; Draelos MM; Steele F; Georgiou M; Praestegaard M
    Dermatol Ther (Heidelb); 2023 Aug; 13(8):1763-1771. PubMed ID: 37351830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of chromameter results obtained from corticosteroid-induced skin blanching assay: comparison of visual and chromameter data.
    Schwarb FP; Smith EW; Haigh JM; Surber C
    Eur J Pharm Biopharm; 1999 May; 47(3):261-7. PubMed ID: 10382110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of efficacy and effect on plasma cortisol levels of micronised desonide cream 0.1 p. 100 versus betamethasone dipropionate cream 0.05 p. 100 In the treatment of childhood atopic dermatitis].
    Lebrun-Vignes B; Legrain V; Amoric J; Taïeb A
    Ann Dermatol Venereol; 2000; 127(6-7):590-5. PubMed ID: 10930856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
    McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
    Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hair removal with the 3-msec alexandrite laser in patients with skin types IV-VI: efficacy, safety, and the role of topical corticosteroids in preventing side effects.
    Aldraibi MS; Touma DJ; Khachemoune A
    J Drugs Dermatol; 2007 Jan; 6(1):60-6. PubMed ID: 17373163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.